Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations
Molecular Therapy · 2026-10 · 34 (10) · 5872-5889
DOI: 10.1016/j.ymthe.2026.07.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Viktor Glaser und 20 weiteren Autor:innen. Beteiligte Einrichtung: Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany; BIH Center for Regenerative Therapies (BCR…. Hauptthemen laut MEDLINE: Gene Editing, T-Lymphocytes, Gene Knock-In Techniques, Translocation, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund, National Institutes of Health National Cancer Institute, European Health and Digital Executive Agency.
Abstract (Originalsprache)
Multiplex genome editing of cellular therapies frequently requires multiple DNA double-strand breaks (DSBs), which can induce genotoxicity through chromosomal rearrangements and large deletions. Base editors enable targeted sequence changes with minimal DSBs and are widely used for gene disruption, but their capacity for transgene insertion has remained unexplored. Here, we have developed base editor-mediated knockin (BEKI), a non-viral platform combining transgene insertion with multiplex gene disruption using a single enzyme. BEKI repurposes the base editor's Cas9 nickase domain to generate paired nicks (inducing a localized DSB) at the knockin locus while achieving multiplex knockouts through base editing. Optimized guide RNA orientation and spacing enabled efficient transgene insertion across multiple T cell-relevant genomic loci. DNA-PK inhibition enhanced knockin efficiency but increased kilobase-scale deletions, which were mitigated by co-inhibition of Polθ. Compared with multiplex Cas9 editing, BEKI markedly reduced chromosomal translocations while preserving cell viability. BEKI supported targeted chimeric antigen receptor (CAR) knockin alongside up to 10 simultaneous gene knockouts, enabling the generation of allogeneic CAR T cells with enhanced cytokine secretion and resistance to immunosuppressants and allo-rejection. Together, BEKI provides a streamlined and scalable strategy for multiplex CAR T cell engineering with improved genomic stability, advancing safer next-generation cell therapies for cancer and autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH), 13353 Berlin, Germany; Institute…
- Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, 79106 Freiburg, Germany; Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germ…
- Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland.
- Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
- BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH), 13353 Berlin, Germany.
Förderung
- Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund
- National Institutes of Health National Cancer Institute
- European Health and Digital Executive Agency
- Cancer Prevention and Research Institute of Texas
- Berlin Institute of Health at Charite
Zitieren
APA
Glaser, V., Becker, L. J., Fuster-García, C., Aird, E. J., Huth, L., Nitulescu, A. M., Pu, Y., Kassing, I., Hartmann, L. M., Flugel, C. L., Kārkliņš, R., Shaji, S., Pouzolles, M., Stein, M., Andrieux, G., Corn, J. E., Cathomen, T., Volk, H. D., Reinke, P., …, & Wagner, D. L. (2026). Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations. Molecular Therapy, 34(10), 5872-5889. https://doi.org/10.1016/j.ymthe.2026.07.034
Vancouver
Glaser V, Becker LJ, Fuster-García C, Aird EJ, Huth L, Nitulescu AM, et al. Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations. Molecular Therapy. 2026;34(10):5872-5889. doi:10.1016/j.ymthe.2026.07.034
BibTeX
@article{Glaser2026,
author = {Glaser, Viktor and Becker, Lily Jo and Fuster-García, Carla and Aird, Eric Jackson and Huth, Luis and Nitulescu, Ana-Maria and Pu, Yaolin and Kassing, Isabell and Hartmann, Laura Marie and Flugel, Christian Luca and Kārkliņš, Roberts and Shaji, Shona and Pouzolles, Marie and Stein, Maik and Andrieux, Geoffroy and Corn, Jacob Ellery and Cathomen, Toni and Volk, Hans-Dieter and Reinke, Petra and Kath, Jonas and Wagner, Dimitrios Laurin},
title = {Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {5872--5889},
doi = {10.1016/j.ymthe.2026.07.034}
}
EUVIMED